Cell proliferation measured by MIBI and timing of surgery for breast cancer
1998

Breast Cancer Surgery Timing and Cell Growth

Sample size: 119 publication Evidence: moderate

Author Information

Author(s): LS Cooper, CE Gillett, P Smith, IS Fentiman, DM Barnes

Primary Institution: Imperial Cancer Research Fund Clinical Oncology Unit

Hypothesis

Does the timing of surgery during the menstrual cycle affect the prognosis of premenopausal women with breast cancer?

Conclusion

The timing of surgery and the level of cell proliferation are significant predictors of survival in premenopausal women with breast cancer.

Supporting Evidence

  • Women with slowly proliferating tumors removed in the luteal phase had a very good prognosis.
  • Patients operated on during the follicular phase had a poorer outcome compared to those operated on during the luteal phase.
  • MIB1 score was significantly associated with overall survival.

Takeaway

This study found that when women have breast cancer surgery during certain times of their menstrual cycle, it can affect how long they live after treatment.

Methodology

The study compared MIB1 staining of tumor samples with flow cytometry to assess cell proliferation and analyzed survival data based on the timing of surgery during the menstrual cycle.

Limitations

The study was limited to a subset of patients and may not be generalizable to all breast cancer patients.

Participant Demographics

All participants were premenopausal women diagnosed with primary infiltrating mammary carcinoma.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication